Emcure Pharmaceuticals is currently trading at RS 943.90, marking an increase of 3.95 points (0.42%) from its previous close of RS 939.95 on the BSE.

The stock opened at RS 954.95, reaching a high of RS 960.10 and a low of RS 938.90. So far, 883 shares have been traded.

This BSE Group 'B' stock, with a face value of RS 10, hit a 52-week high of RS 1577.50 on 18-Sep-2024 and a 52-week low of RS 935.00 on 03-Mar-2025. Over the past week, it traded between RS 999.50 (high) and RS 935.05 (low). The company's market capitalization stands at RS 17,880.47 crore.

In terms of shareholding, promoters hold 77.94%, while institutions and non-institutions hold 6.92% and 15.14%, respectively.

Expansion in Daily Supplements Market

Emcure Pharmaceuticals has expanded its Arth range into the daily supplements segment, combining traditional Indian herbs like Brahmi with modern scientific precision. The supplements aim to address key health concerns.

To promote women’s health and quality supplements, Emcure has partnered with acclaimed actor Vidya Balan as the brand ambassador for Arth. As part of this collaboration, she will highlight three key products:

• Intimate Care – Soothes itchiness and dryness in intimate areas.
• Sleep Support Gummies – Promotes quality sleep.
• Brain Fog Aid – Enhances focus and cognition.

About Emcure Pharmaceuticals

Emcure Pharmaceuticals is a leading Indian pharmaceutical company engaged in the development, manufacturing, and global marketing of a broad range of pharmaceutical products across major therapeutic areas.